Status:
COMPLETED
Atacand (Candesartan) Real Life Study
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Eligibility:
All Genders
17+ years
Brief Summary
This study is a Swedish historical cohort study in patients prescribed Atacand or Cozaar for hypertension by selected primary care centres. Data will be extracted anonymously from electronic medical r...
Eligibility Criteria
Inclusion
- Recorded blood pressure prior to therapy of \> 140 and/or 90 mmHg
- Diagnosed as hypertensive within 15 months
- First prescription of Cozaar or Atacand between 1 January 1999 and 31 December 2007, inclusive
Exclusion
- Previous prescription within 15 months any drug from the ATC groups C02, C03, C07 - C09 inclusive
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
14000 Patients enrolled
Trial Details
Trial ID
NCT00620178
Start Date
March 1 2008
End Date
February 1 2009
Last Update
December 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Uppsala, Sweden